Susquehanna Fundamental Investments’s Precigen PGEN Stock Holding History

Susquehanna Fundamental Investments’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-39,355	Closed	-$83K	–	1409
2022 Q3	$83K	Buy	+39,355	New	+$83K	﹤0.01%	1350
2022 Q1	$409K	Hold	193,791	–	–	0.01%	1150
2021 Q4	$719K	Buy	193,791 +68,003	+54%	+$293K	0.02%	781
2021 Q3	$628K	Buy	125,788 +11,371	+10%	+$65.5K	0.01%	1091
2021 Q2	$746K	Sell	114,417 -43,782	-28%	-$306K	0.01%	987
2021 Q1	$1.09M	Hold	158,199	–	–	0.02%	856
2020 Q4	$1.61M	Buy	158,199 +8,400	+6%	+$54.5K	0.03%	696
2020 Q3	$524K	Buy	149,799 +30,900	+26%	+$147K	0.02%	860
2020 Q2	$593K	Buy	+118,899	New	+$404K	0.03%	567
2020 Q1	–	Sell	-15,000	Closed	-$82K	–	382
2019 Q4	$82K	Hold	15,000	–	–	0.01%	307
2019 Q3	$86K	Hold	15,000	–	–	0.01%	311
2019 Q2	$115K	Buy	+15,000	New	+$80.8K	0.01%	335

Other funds holding PGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna Fundamental Investments's PGEN Position: Q4 2022 in Review

Susquehanna Fundamental Investments sold out of Precigen (PGEN) in Q4 2022, closing a stake of 39,355 shares — an estimated $83K sold.

Susquehanna Fundamental Investments first reported a position in PGEN in Q2 2019 and held it in 12 quarters. The position peaked at $1.61M in Q4 2020. 161 funds tracked by Wall St. Rank hold PGEN as of Q4 2022.

Susquehanna Fundamental Investments reported no remaining Precigen position as of Q4 2022 after selling out during the quarter.
Susquehanna Fundamental Investments sold 39,355 Precigen shares in Q4 2022, an estimated $83K.
Susquehanna Fundamental Investments first reported a position in Precigen in Q2 2019 and held it in 12 quarters.
Susquehanna Fundamental Investments's Precigen position peaked at $1.61M in Q4 2020.
161 funds tracked by Wall St. Rank held Precigen as of Q4 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2022, filed 14 Feb 2023.